Anúncio
Anúncio
WST
West Pharmaceutical Services, Inc.
278.51
USDPatrocinado
-2.32
-0.83%
07 de jan., 15:59 UTC -5
Abrir
Relatórios de Lucros WST
Rácio de surpresa positiva
WST separação 34 de 39 últimas estimativas.
87%
Próximo Relatório
Data do Próximo Relatório
11 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$802.87M
/$1.85
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-0.21%
/-5.61%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+7.22%
/+1.65%
West Pharmaceutical Services, Inc. earnings per share and revenue
On 23 de out. de 2025, WST reported earnings of 1.96 USD per share (EPS) for Q3 25, beating the estimate of 1.69 USD, resulting in a 15.40% surprise. Revenue reached 804.60 milhão, compared to an expected 795.81 milhão, with a 1.10% difference. The market reacted with a +10.92% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analistas forecast an EPS of 1.85 USD, with revenue projected to reach 802.87 milhão USD, implying an diminuir of -5.61% EPS, and diminuir of -0.21% in Revenue from the last quarter.
FAQ
What were West Pharmaceutical Services, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, West Pharmaceutical Services, Inc. reported EPS of $1.96, beating estimates by 15.4%, and revenue of $804.60M, 1.1% above expectations.
How did the market react to West Pharmaceutical Services, Inc.'s Q3 2025 earnings?
The stock price moved up 10.92%, changed from $277.00 before the earnings release to $307.25 the day after.
When is West Pharmaceutical Services, Inc. expected to report next?
The next earning report is scheduled for 11 de fev. de 2026.
What are the forecasts for West Pharmaceutical Services, Inc.'s next earnings report?
Based on 16
analistas, West Pharmaceutical Services, Inc. is expected to report EPS of $1.85 and revenue of $802.87M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio